No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ACCD240816C2500
- 1.12
- +0.18+19.15%
15min DelayClose Jul 22 16:00 ET
1.12High1.12Low
1.12Open0.94Pre Close135 Volume355 Open Interest2.50Strike Price15.12KTurnover0.00%IV-3.21%PremiumAug 16, 2024Expiry Date1.24Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.48Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Leerink Partners Maintains Accolade(ACCD.US) With Buy Rating, Maintains Target Price $9.5
Leerink Partners analyst Michael Cherny maintains $Accolade(ACCD.US)$ with a buy rating, and maintains the target price at $9.5.According to TipRanks data, the analyst has a success rate of 49.8%
Wells Fargo Maintains Accolade(ACCD.US) With Hold Rating, Maintains Target Price $7
Wells Fargo analyst Stan Berenshteyn maintains $Accolade(ACCD.US)$ with a hold rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 51.8% and a
BofA Securities Maintains Accolade(ACCD.US) With Buy Rating
BofA Securities analyst Allen Lutz maintains $Accolade(ACCD.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 46.9% and a total average return of -1.5% over the
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Express News | Accolade Inc : Jefferies Cuts Target Price to $4 From $9
Express News | Accolade Inc : Raymond James Cuts Target Price to $11 From $16
Comments
$Accolade(ACCD.US$ lol now competition to cut target price.
Accolade's balance sheet seems manageable with its US$741.6m market cap, but needs monitoring. Its future profitability will impact its financial strength. However, its EBIT loss, negative free cash outflow of US$37m, and a US$123m accounting loss make it somewhat risky.
1
Investors seem to be banking on Accolade's strong future outlook, despite its slow growth in revenue. The high P/S ratio and share price suggest confidence in the company's future revenues.
Gainers:
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
18
1
Upgrades
• $Accolade(ACCD.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $6 (from $9)
• $Comerica(CMA.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $94 (from $90)
• $New Oriental(EDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $14 (from $35)
• $EPAM Systems(EPAM.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $348 (from $359)
• $Empire State Realty Trust Inc(ESRT.US$ : Evercore ISI Upgrades to Outp...
• $Accolade(ACCD.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $6 (from $9)
• $Comerica(CMA.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $94 (from $90)
• $New Oriental(EDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $14 (from $35)
• $EPAM Systems(EPAM.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $348 (from $359)
• $Empire State Realty Trust Inc(ESRT.US$ : Evercore ISI Upgrades to Outp...
18
1
thank youRead more